Article ID Journal Published Year Pages File Type
2504055 International Journal of Pharmaceutics 2010 9 Pages PDF
Abstract

A brush-shaped polymer PHEMA-g-(PEI-b-PEG) with poly(2-hydroxyethyl methacrylate) (PHEMA) backbone and linear poly(ethylenimine)-b-poly(ethylene glycol) (PEI-b-PEG) side chains was synthesized and evaluated as a vector for potential cancer gene therapy. The characterizations by 1H NMR and laser light scattering demonstrated the brush structure of the polymer. PHEMA-g-(PEI-b-PEG) was much less cytotoxic when compared with branched poly(ethylenimine) with Mw of 25 kDa. The capacity of plasmid DNA condensation by PHEMA-g-(PEI-b-PEG) was demonstrated by gel retardation assay, and they formed nanosized complexes with surface zeta potential around 20 mV at N/P ratios higher than 5:1. The complexes of PHEMA-g-(PEI-b-PEG) with plasmid DNA were more efficiently internalized by BT474 cells in comparison with the complexes of PEI25K, leading to higher gene transfection in cells. Further investigation using complexes of PHEMA-g-(PEI-b-PEG) with plasmid DNA encoding wild-type p53 gene showed its potential as a carrier for cancer gene therapy. The complexes of PHEMA-g-(PEI-b-PEG) successfully induced elevated wild-type p53 expression in BT474 cells and led to enhanced apoptosis of BT474 cells. Transfection of wild-type p53 using the complexes also significantly increased the sensitivity of BT474 cells to doxorubicin chemotherapy, suggesting the potential of this carrier in cancer gene therapy.

Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmaceutical Science
Authors
, , , , , ,